familial syndromes and the benefits of multi-gene panel testing in breast cancer: 2022 esmo florida
Published 1 year ago • 30 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
0:33
treating patients with breast cancer and a brca 1/2 mutation: 2022 esmo florida
-
2:37
genomic classifiers in breast cancer: prognostic and predictive information: 2022 esmo florida
-
1:08
refining classification and staging in breast cancer – biology matters alot: 2022 esmo florida
-
0:59
using genomic assays for clinical decision making in early breast cancer: 2022 esmo florida
-
2:00
testing patients for brca 1/2 mutation – guiding treatment, and reducing risk: 2022 esmo florida
-
55:32
testing in mbc
-
48:45
acute lymphoblastic leukemia (all)
-
4:06
fda approves kisqali / ribociclib for early high-risk breast cancer esmo 2024
-
28:57
2021 force | hereditary cancer | cancer risks, screening & prevention for brca1 or brca2 mutations
-
1:38
precision oncology in gist and the importance of mutational testing: 2022 esmo florida
-
58:35
special re-broadcast: multi-cancer early detection blood test.
-
0:49
breast cancer at esmo 2023: adcs and monarch 3
-
0:30
new classifications and staging in breast cancer | jodi widner, md | esmo22 colorado
-
1:57
a flurry of new drug development and approvals in breast cancer: 2022 esmo florida
-
2:40
emergence of antibody-drug conjugates in metastatic breast cancer: 2022 esmo florida
-
30:44
genetic testing and management of breast cancer susceptibility germline mutations
-
0:30
key takeaways in breast cancer from esmo 2022
-
0:51
“moving the needle” in the metastatic breast cancer setting: 2022 esmo florida
-
4:09
doctor explains brca1 & brca2 genetic testing for inherited breast and ovarian cancer...
-
3:37
genetics testing outside brca | jennifer klemp, phd, mph, ma | esmo22 colorado
-
1:06
bringing the eu and the us together with cutting edge technologies in oncology: 2022 esmo florida